Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
BIB Seed Capital (also known as BIB Seed Fund) is a Polish venture capital firm based in Poznań, specializing in the commercialization of scientific and technological achievements in the life sciences. Founded in 2007 by Marcin Hoffmann and Leszek Rychlewski, the fund focuses on high-tech sectors including biotechnology, molecular biology, pharmaceutical chemistry, and bioinformatics. It facilitates the transfer of technology from Polish academic institutions to the market, providing seed-stage investment and strategic support to innovative startups. Notable portfolio successes include Medicalgorithmics, a leader in cardiac diagnostics, and Proteon Pharmaceuticals, which develops bacteriophage-based therapies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on BIB Seed Fund.